Hero

UCB Pharma GmbH

Main Industry
Pharmacy
updated 
updated 

Key Facts

This company profile is a search result of implisense.com

E-Mail

Industries

Pharmacy (C21)

Products and Services

StudienEntwicklungForschung

Size (Revenue & Employees)

Large company

Balance sheet total

2 B €

Purpose

Die Herstellung von, der Vertrieb von und der Handel mit Arzneimitteln und sonstigen pharmazeutisch-chemischen oder kosmetischen Produkten.

More? Implisense Plus!

Order Implisense Plus now for full company profiles and complete functionality! Your benefits:

  • Real-time search for contact persons
  • Complete annual reports
  • More search filters and results
Implisense Plus

Executive Summary

Implisense Assist gives you the opportunity to use AI to find out about companies via chat, analyze them and much more. We from the Implisense team also provide you with ready-made analyses, e.g., an executive summary and a financial analysis. Just try it out for yourself!

Implisense Plus
implisense assist

profile random user logo

implisense assist

Contacts

  • Karl-Werner Leffers
  • Kirsten Wittling
  • Hanna Rabia Khan

One authorized signatory

Show more

Timeline

UCB Pharma GmbH 2023: Eigenkapitalquote sowie Anlagevermögen erhöhen sich!

Die UCB Pharma GmbH verzeichnete eine Zunahme der Eigenkapitalquote um % verglichen mit dem Vorjahr sowie des Anlagevermögens von % auf Euro. Diese Entwicklung zeigt unter Umständen eine Erhöhung der langfristigen Investitionen. Der neueste Jahresabschluss für das Fiskaljahr 2023 steht jetzt zur Verfügung und liefert detaillierte Kennzahlen und Analysen.

Veränderung im Handelsregister

Abschluss des Förderprojektes "Verbundprojekt: Zentrale IT-Plattform und ProMiner RDF Erweiterung - Neuro-I2B -" (BMBF 16GW0013)

Heute endet das Förderprojekt "Verbundprojekt: Zentrale IT-Plattform und ProMiner RDF Erweiterung - Neuro-I2B -". Es wurde vom BMBF unter dem Förderkennzeichen 16GW0013 für die UCB Pharma GmbH mit einer Summe von 105.521,00 Euro gefördert. Die Laufzeit des Projektes betrug 60 Monate.

Abschluss des Förderprojektes "Verbundprojekt: Biopharma-Neuroallianz: Strukturelle Weiterentwicklung des Neuroallianz-Konsortiums mit dem Fokus auf Nachhaltigkeit - Neuro-MB -" (BMBF 16GW0037K)

Heute endet das Förderprojekt "Verbundprojekt: Biopharma-Neuroallianz: Strukturelle Weiterentwicklung des Neuroallianz-Konsortiums mit dem Fokus auf Nachhaltigkeit - Neuro-MB -". Es wurde vom BMBF unter dem Förderkennzeichen 16GW0037K für die UCB Pharma GmbH mit einer Summe von 353.825,00 Euro gefördert. Die Laufzeit des Projektes betrug 44 Monate.

Abschluss des Förderprojektes "Verbundprojekt: Identification of prediction and progression biomarkers in the earliest stages of Parkinson's disease - Neuro-D13B -" (BMBF 16GW0066K)

Heute endet das Förderprojekt "Verbundprojekt: Identification of prediction and progression biomarkers in the earliest stages of Parkinson's disease - Neuro-D13B -". Es wurde vom BMBF unter dem Förderkennzeichen 16GW0066K für die UCB Pharma GmbH mit einer Summe von 266.688,00 Euro gefördert. Die Laufzeit des Projektes betrug 42 Monate.

Network

Discover connections between companies via managers, shareholdings, links or addresses here.

Register to see more connections via management and web links. Get access to an interactive network to better understand the environment of this company.

Show more

Products & Technologies

Studien
Entwicklung
Forschung
Software
Arzneimittel
Medikamente
Immunologie
Hardware
Dienstleistungen
See all 20 entries

Register for a free Implisense account to get advanced analysis and more extensive search results.

Show more

UCB Pharma GmbH is mentioned in public sources in the context of the following products and services. Studien, Entwicklung and Forschung are the most common. The ranking list shown is without guarantee of completeness or correctness.

Artificial IntelligenceKünstliche Intelligenz
Big DataBig Data Technology
Microsoft ProductsMicrosoft Office

The following software solutions, technologies and concepts are often referenced in job postings and press releases of UCB Pharma GmbH. Most frequently recognized were Künstliche Intelligenz, Big Data Technology and Microsoft Office.

Dominance, Competence, ClarityInnovation, Passion, CreativityHarmony, Reliability, CommunicatibilityDilligence, Introspection, Thoroughness

Dominance, Competence, Clarity

Innovation, Passion, Creativity

Harmony, Reliability, Communicatibility

Dilligence, Introspection, Thoroughness

The 4 Color Scheme separates people and their personalities into four groups. UCB Pharma GmbH emphasizes the following character types in their external communications and job advertisements.

You can find more information on the FAQ page.

Information for Job Seekers

Based on job advertisements of UCB Pharma GmbH, the following specific requirements for job seekers were identified more frequently. Specific requirements can be found in the latest published job advertisements.

Methodische Kompetenz

  • Zielorientierung
  • Eigeninitiative
  • Kundenorientierung
  • Kommunikationsstärke

Persönliche Kompetenz

  • Einsatzbereitschaft
  • Motivation
  • Selbstmanagement
  • Beharrlichkeit

Soziale Kompetenz

  • Teamfähigkeit
  • Emotionale Intelligenz
  • Diskretion
  • Umgangsformen

The following additional requirements were identified more frequently. These may vary and are provided for guidance.

  • Reisebereitschaft
  • Sprachkenntnisse

The following benefits were repeatedly recognized in job postings of UCB Pharma GmbH. This data is supplied without liability and intended for orientation purposes only.

Essen & TrinkenBetriebsgastronomie
TeamkulturSommerfest
Weitere BenefitsBetriebsrat
Register your Implisense account for free

Register now for a free Implisense account. Registered users have access to advanced analyses and more key figures on company profiles, receive more extensive search results and can also create and manage their own favorites.

  • Richer Company Profiles
  • Expanded Search Results
  • Personal Favourites
The company information presented on implisense.com comes from public sources and is verified and aggregated automatically. Implisense cannot guarantee the timeliness, completeness, quality, reliability or accuracy of the data. For questions or suggestions, please use the contact form.

This website uses cookies to provide this service and improve the user experience. Please select the cookies you wish to accept. You can find further information in our data protection declaration.

Some cookies from this site are necessary for the functionality of this service or enhance the user experience. Since these cookies either do not contain any personal data (e.g. language preference) or are very short-lived (e.g. session ID), cookies from this group are mandatory and cannot be deactivated.
To improve our services, we use user statistics such as Google Analytics, which set cookies for user identification. Google Analytics is a service offered by a third party provider.
To improve our services we use proprietary marketing solutions from third parties. These solutions specifically include Google AdWords and Google Optimize, which each set one or more cookies.
Some cookies from this site are necessary for the functionality of this service or enhance the user experience. Since these cookies either do not contain any personal data (e.g. language preference) or are very short-lived (e.g. session ID), cookies from this group are mandatory and cannot be deactivated.Some cookies from this site are necessary for the functionality of this service or enhance the user experience. Since these cookies either do not contain any personal data (e.g. language preference) or are very short-lived (e.g. session ID), cookies from this group are mandatory and cannot be deactivated.
To improve our services, we use user statistics such as Google Analytics, which set cookies for user identification. Google Analytics is a service offered by a third party provider.Some cookies from this site are necessary for the functionality of this service or enhance the user experience. Since these cookies either do not contain any personal data (e.g. language preference) or are very short-lived (e.g. session ID), cookies from this group are mandatory and cannot be deactivated.
To improve our services we use proprietary marketing solutions from third parties. These solutions specifically include Google AdWords and Google Optimize, which each set one or more cookies.Some cookies from this site are necessary for the functionality of this service or enhance the user experience. Since these cookies either do not contain any personal data (e.g. language preference) or are very short-lived (e.g. session ID), cookies from this group are mandatory and cannot be deactivated.

Save selectionSelect all